Riccardo Calandrelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Riccardo Calandrelli has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Sheng Zhong
Shu Chien-Gene Lay Department of Bioengineering, University of California San Diego
12 shared publications - Zhen Bouman Chen
Department of Diabetes Complications and Metabolism, Beckman Research Institute, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, USA
6 shared publications - Naseeb Kaur Malhi
Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes and Metabolism Research Institute and Beckman Research Institute of City of Hope, Duarte, CA 91010, USA
3 shared publications - Qiuyang Wu
Genemo Inc., San Diego, CA 92121
3 shared publications - Rama Natarajan
Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes and Metabolism Research Institute and Beckman Research Institute of City of Hope, Duarte, CA 91010, USA
3 shared publications Weixin Wu
Department of Bioengineering, Center for Epigenomics, University of California San Diego, La Jolla, CA, USA
3 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 8 (3) , lqag067
Long non-coding RNA triplex-dependent regulation of melanoma gene networks
SLNCR is a long non-coding RNA (lncRNA) that promotes melanoma formation. Previously, we have shown that SLNCR regulates gene expression via its interactions with different transcription factors. Here we show that SLNCR is associated with several genomic sites that contain RNA•DNA triplex target sites (TTSs). The primary sequence of SLNCR contains four triplex-forming regions (TFRs), which are homologous to the TFRs of MEG3, HOTAIR, and PARTICLE lncRNAs. Full-length SLNCR overexpression promotes proliferation, migration, and invasion of melanoma cells by inducing characteristic gene expression changes of genes that are enriched in pathways involved in cell cycle regulation and cell migration. The transcriptomic signature of full-length SLNCR is reversed by deletions of TFR1, 2, 3, or 4. Full-length SLNCR is structurally flexible and permissive of different interactions with the DNA and/or proteins. Deletion of any individual TFR causes SLNCR to gain structural definition, potentially preventing some of its native interactions. Using RNA sequencing and the Triplex Domain Finder tool, we demonstrate that SLNCR TFRs form RNA•DNA:DNA triplexes with the TTSs in promoters of key genes (nodes) predicted to regulate melanoma migration and invasion networks. We further validate the effect on invasion using A375 cells in functional assays. Finally, inhibitory oligos that block SLNCR•DNA:DNA triplex formation reversed the effect of SLNCR-mediated migration ex vivo, demonstrating that triplex formation plays a role in driving melanoma progression.
- 27 June 2026
- Published by Oxford University Press (OUP) in NAR Genomics and Bioinformatics
- Vol. 8 (3) , lqag067
Open AccessLong non-coding RNA triplex-dependent regulation of melanoma gene networks
SLNCR is a long non-coding RNA (lncRNA) that promotes melanoma formation. Previously, we have shown that SLNCR regulates gene expression via its interactions with different transcription factors. Here we show that SLNCR is associated with several genomic sites that contain RNA•DNA triplex target sites (TTSs). The primary sequence of SLNCR contains four triplex-forming regions (TFRs), which are homologous to the TFRs of MEG3, HOTAIR, and PARTICLE lncRNAs. Full-length SLNCR overexpression promotes proliferation, migration, and invasion of melanoma cells by inducing characteristic gene expression changes of genes that are enriched in pathways involved in cell cycle regulation and cell migration. The transcriptomic signature of full-length SLNCR is reversed by deletions of TFR1, 2, 3, or 4. Full-length SLNCR is structurally flexible and permissive of different interactions with the DNA and/or proteins. Deletion of any individual TFR causes SLNCR to gain structural definition, potentially preventing some of its native interactions. Using RNA sequencing and the Triplex Domain Finder tool, we demonstrate that SLNCR TFRs form RNA•DNA:DNA triplexes with the TTSs in promoters of key genes (nodes) predicted to regulate melanoma migration and invasion networks. We further validate the effect on invasion using A375 cells in functional assays. Finally, inhibitory oligos that block SLNCR•DNA:DNA triplex formation reversed the effect of SLNCR-mediated migration ex vivo, demonstrating that triplex formation plays a role in driving melanoma progression.
- Open Access
High-Resolution Characterization of Human Brain Cortex with High-Fidelity Spatial Transcriptomic Slides (HiFi-Slides)
Spatial transcriptomic tools and platforms help researchers to inspect tissues and cells with fine details of how they differentiate in expressions and how they orient themselves. With the higher resolution we get and higher throughput of expression targets, spatial analysis can truly become the core player for cell clustering, migration study, and, eventually, the novel model for pathological study. We present the demonstration of HiFi-slide, a whole transcriptomic sequencing technique that recycles used sequenced-by-synthesis flow cell surfaces to a high-resolution spatial mapping tool that can be directly applied to tissue cell gradient analysis, gene expression analysis, cell proximity analysis, and other cellular-level spatial studies.
Open AccessHigh-Resolution Characterization of Human Brain Cortex with High-Fidelity Spatial Transcriptomic Slides (HiFi-Slides)
Spatial transcriptomic tools and platforms help researchers to inspect tissues and cells with fine details of how they differentiate in expressions and how they orient themselves. With the higher resolution we get and higher throughput of expression targets, spatial analysis can truly become the core player for cell clustering, migration study, and, eventually, the novel model for pathological study. We present the demonstration of HiFi-slide, a whole transcriptomic sequencing technique that recycles used sequenced-by-synthesis flow cell surfaces to a high-resolution spatial mapping tool that can be directly applied to tissue cell gradient analysis, gene expression analysis, cell proximity analysis, and other cellular-level spatial studies.
- Open Access
- 15 May 2023
- Published by MDPI AG in Non-Coding RNA
- Vol. 9 (3) , 31
Genetic Deletion of the LINC00520 Homolog in Mouse Aggravates Angiotensin II-Induced Hypertension
(1) Background: Hypertension is a complex, multifactorial disease that is caused by genetic and environmental factors. Apart from genetic predisposition, the mechanisms involved in this disease have yet to be fully understood. We previously reported that LEENE (lncRNA enhancing endothelial nitric oxide expression, transcribed from LINC00520 in the human genome) regulates endothelial cell (EC) function by promoting the expression of endothelial nitric oxide synthase (eNOS) and vascular growth factor receptor 2 (VEGFR2). Mice with genetic deletion of the LEENE/LINC00520 homologous region exhibited impaired angiogenesis and tissue regeneration in a diabetic hindlimb ischemia model. However, the role of LEENE in blood pressure regulation is unknown. (2) Methods: We subjected mice with genetic ablation of leene and wild-type littermates to Angiotensin II (AngII) and monitored their blood pressure and examined their hearts and kidneys. We used RNA-sequencing to identify potential leene-regulated molecular pathways in ECs that contributed to the observed phenotype. We further performed in vitro experiments with murine and human ECs and ex vivo experiments with murine aortic rings to validate the select mechanism. (3) Results: We identified an exacerbated hypertensive phenotype of leene-KO mice in the AngII model, evidenced by higher systolic and diastolic blood pressure. At the organ level, we observed aggravated hypertrophy and fibrosis in the heart and kidney. Moreover, the overexpression of human LEENE RNA, in part, restored the signaling pathways impaired by leene deletion in murine ECs. Additionally, Axitinib, a tyrosine kinase inhibitor that selectively inhibits VEGFR suppresses LEENE in human ECs. (4) Conclusions: Our study suggests LEENE as a potential regulator in blood pressure control, possibly through its function in ECs.
- 15 May 2023
- Published by MDPI AG in Non-Coding RNA
- Vol. 9 (3) , 31
Open AccessGenetic Deletion of the LINC00520 Homolog in Mouse Aggravates Angiotensin II-Induced Hypertension
(1) Background: Hypertension is a complex, multifactorial disease that is caused by genetic and environmental factors. Apart from genetic predisposition, the mechanisms involved in this disease have yet to be fully understood. We previously reported that LEENE (lncRNA enhancing endothelial nitric oxide expression, transcribed from LINC00520 in the human genome) regulates endothelial cell (EC) function by promoting the expression of endothelial nitric oxide synthase (eNOS) and vascular growth factor receptor 2 (VEGFR2). Mice with genetic deletion of the LEENE/LINC00520 homologous region exhibited impaired angiogenesis and tissue regeneration in a diabetic hindlimb ischemia model. However, the role of LEENE in blood pressure regulation is unknown. (2) Methods: We subjected mice with genetic ablation of leene and wild-type littermates to Angiotensin II (AngII) and monitored their blood pressure and examined their hearts and kidneys. We used RNA-sequencing to identify potential leene-regulated molecular pathways in ECs that contributed to the observed phenotype. We further performed in vitro experiments with murine and human ECs and ex vivo experiments with murine aortic rings to validate the select mechanism. (3) Results: We identified an exacerbated hypertensive phenotype of leene-KO mice in the AngII model, evidenced by higher systolic and diastolic blood pressure. At the organ level, we observed aggravated hypertrophy and fibrosis in the heart and kidney. Moreover, the overexpression of human LEENE RNA, in part, restored the signaling pathways impaired by leene deletion in murine ECs. Additionally, Axitinib, a tyrosine kinase inhibitor that selectively inhibits VEGFR suppresses LEENE in human ECs. (4) Conclusions: Our study suggests LEENE as a potential regulator in blood pressure control, possibly through its function in ECs.
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S691
Abstract 2591: The 4D Nucleome Program
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S691
Open AccessAbstract 2591: The 4D Nucleome Program
- Open Access
- 1 February 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (3)
Long noncoding RNA LEENE promotes angiogenesis and ischemic recovery in diabetes models
Impaired angiogenesis in diabetes is a key process contributing to ischemic diseases such as peripheral arterial disease. Epigenetic mechanisms, including those mediated by long noncoding RNAs (lncRNAs), are crucial links connecting diabetes and the related chronic tissue ischemia. Here we identify the lncRNA that enhances endothelial nitric oxide synthase (eNOS) expression (LEENE) as a regulator of angiogenesis and ischemic response. LEENE expression was decreased in diabetic conditions in cultured endothelial cells (ECs), mouse hind limb muscles, and human arteries. Inhibition of LEENE in human microvascular ECs reduced their angiogenic capacity with a dysregulated angiogenic gene program. Diabetic mice deficient in Leene demonstrated impaired angiogenesis and perfusion following hind limb ischemia. Importantly, overexpression of human LEENE rescued the impaired ischemic response in Leene-knockout mice at tissue functional and single-cell transcriptomic levels. Mechanistically, LEENE RNA promoted transcription of proangiogenic genes in ECs, such as KDR (encoding VEGFR2) and NOS3 (encoding eNOS), potentially by interacting with LEO1, a key component of the RNA polymerase II–associated factor complex and MYC, a crucial transcription factor for angiogenesis. Taken together, our findings demonstrate an essential role for LEENE in the regulation of angiogenesis and tissue perfusion. Functional enhancement of LEENE to restore angiogenesis for tissue repair and regeneration may represent a potential strategy to tackle ischemic vascular diseases.
- 1 February 2023
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (3)
Open AccessLong noncoding RNA LEENE promotes angiogenesis and ischemic recovery in diabetes models
Impaired angiogenesis in diabetes is a key process contributing to ischemic diseases such as peripheral arterial disease. Epigenetic mechanisms, including those mediated by long noncoding RNAs (lncRNAs), are crucial links connecting diabetes and the related chronic tissue ischemia. Here we identify the lncRNA that enhances endothelial nitric oxide synthase (eNOS) expression (LEENE) as a regulator of angiogenesis and ischemic response. LEENE expression was decreased in diabetic conditions in cultured endothelial cells (ECs), mouse hind limb muscles, and human arteries. Inhibition of LEENE in human microvascular ECs reduced their angiogenic capacity with a dysregulated angiogenic gene program. Diabetic mice deficient in Leene demonstrated impaired angiogenesis and perfusion following hind limb ischemia. Importantly, overexpression of human LEENE rescued the impaired ischemic response in Leene-knockout mice at tissue functional and single-cell transcriptomic levels. Mechanistically, LEENE RNA promoted transcription of proangiogenic genes in ECs, such as KDR (encoding VEGFR2) and NOS3 (encoding eNOS), potentially by interacting with LEO1, a key component of the RNA polymerase II–associated factor complex and MYC, a crucial transcription factor for angiogenesis. Taken together, our findings demonstrate an essential role for LEENE in the regulation of angiogenesis and tissue perfusion. Functional enhancement of LEENE to restore angiogenesis for tissue repair and regeneration may represent a potential strategy to tackle ischemic vascular diseases.
- Open Access
Regulation of Nuclear Transcription by Mitochondrial RNA
Mitochondrial-nuclear communication is vital for cellular homeostasis and stress response. Mitochondria employ messengers e.g., metabolites, peptides, and Ca2+ to communicate to the nucleus. It remains unclear whether mitochondrial RNAs (mtRNAs), the immediate output of mitochondrial transcription, can serve as a messenger for communication to the nucleus. We show that mtRNAs are attached to the nuclear genome and constitute a subset of the chromatin-associated RNA, and hence termed mt-caRNA. Mt-caRNAs preferentially attach to promoter regions and the attachment levels change in response to cellular stress. In human endothelial cells (ECs), suppression of SncmtRNA, a mitochondrial non-coding RNA associated with chromatins, attenuates stress induction of nuclear-transcribed nascent RNAs, including cell adhesion molecules ICAM1 and VCAM1, and abolishes stress-induced monocyte-EC adhesion. In addition, we show nuclear localization of MT-CYB and MT-ND5 in human ECs, a phenomenon potentiated in ECs from diabetic donors. Collectively, our findings suggest the involvement of mtRNAs in mitochondrial-nuclear communications and that mt-caRNAs may regulate nuclear transcription and cellular function. Teaser Mitochondria-encoded RNAs can attach to nuclear chromatin and regulate nuclear transcription and cell function in response to stress.
Open AccessRegulation of Nuclear Transcription by Mitochondrial RNA
Mitochondrial-nuclear communication is vital for cellular homeostasis and stress response. Mitochondria employ messengers e.g., metabolites, peptides, and Ca2+ to communicate to the nucleus. It remains unclear whether mitochondrial RNAs (mtRNAs), the immediate output of mitochondrial transcription, can serve as a messenger for communication to the nucleus. We show that mtRNAs are attached to the nuclear genome and constitute a subset of the chromatin-associated RNA, and hence termed mt-caRNA. Mt-caRNAs preferentially attach to promoter regions and the attachment levels change in response to cellular stress. In human endothelial cells (ECs), suppression of SncmtRNA, a mitochondrial non-coding RNA associated with chromatins, attenuates stress induction of nuclear-transcribed nascent RNAs, including cell adhesion molecules ICAM1 and VCAM1, and abolishes stress-induced monocyte-EC adhesion. In addition, we show nuclear localization of MT-CYB and MT-ND5 in human ECs, a phenomenon potentiated in ECs from diabetic donors. Collectively, our findings suggest the involvement of mtRNAs in mitochondrial-nuclear communications and that mt-caRNAs may regulate nuclear transcription and cellular function. Teaser Mitochondria-encoded RNAs can attach to nuclear chromatin and regulate nuclear transcription and cell function in response to stress.
- 3 May 2022
- Published by Elsevier in Cell Metabolism
- Vol. 34 (5) , 651-653
PHGDH expression increases with progression of Alzheimer’s disease pathology and symptoms
- 3 May 2022
- Published by Elsevier in Cell Metabolism
- Vol. 34 (5) , 651-653
PHGDH expression increases with progression of Alzheimer’s disease pathology and symptoms
- Open Access
Sequential increase of PHGDH expression with Alzheimer’s pathology and symptoms
We report consistent increases in phosphoglycerate dehydrogenase (PHGDH) expression in mouse models of Alzheimer’s disease (AD) (3xTg-AD) and related tauopathy (PS19), particularly in hippocampal astrocytes. Human single-cell RNA-sequencing data reveal a sequential increase of PHGDH expression in people with no, early, and late AD pathology, which is corroborated by protein mass spectrometry and immunohistochemical analyses of three independent cohorts. A sequential increase of PHGDH expression also correlates with increasing clinical AD symptoms and worsening cognitive decline in patients. The consistent increase of PHGDH expression in six AD cohorts (Mayo, ROSMAP, Mount Sinai, Baltimore, Amsterdam, and UCSD/UCI) corroborates with the recent report of PHGDH extracellular RNA in blood plasma as a candidate biomarker for early diagnosis of AD and offers a caution to the suggested use of L-serine as a potential therapy of AD.
Open AccessSequential increase of PHGDH expression with Alzheimer’s pathology and symptoms
We report consistent increases in phosphoglycerate dehydrogenase (PHGDH) expression in mouse models of Alzheimer’s disease (AD) (3xTg-AD) and related tauopathy (PS19), particularly in hippocampal astrocytes. Human single-cell RNA-sequencing data reveal a sequential increase of PHGDH expression in people with no, early, and late AD pathology, which is corroborated by protein mass spectrometry and immunohistochemical analyses of three independent cohorts. A sequential increase of PHGDH expression also correlates with increasing clinical AD symptoms and worsening cognitive decline in patients. The consistent increase of PHGDH expression in six AD cohorts (Mayo, ROSMAP, Mount Sinai, Baltimore, Amsterdam, and UCSD/UCI) corroborates with the recent report of PHGDH extracellular RNA in blood plasma as a candidate biomarker for early diagnosis of AD and offers a caution to the suggested use of L-serine as a potential therapy of AD.
- Open Access
Genome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells
The interphase genome is dynamically organized in the nucleus and decorated with chromatin-associated RNA (caRNA). It remains unclear whether the genome architecture modulates the spatial distribution of caRNA and vice versa. Here, we generate a resource of genome-wide RNA-DNA and DNA-DNA contact maps in human cells. These maps reveal the chromosomal domains demarcated by locally transcribed RNA, hereafter termed RNA-defined chromosomal domains. Further, the spreading of caRNA is constrained by the boundaries of topologically associating domains (TADs), demonstrating the role of the 3D genome structure in modulating the spatial distribution of RNA. Conversely, stopping transcription or acute depletion of RNA induces thousands of chromatin loops genome-wide. Activation or suppression of the transcription of specific genes suppresses or creates chromatin loops straddling these genes. Deletion of a specific caRNA-producing genomic sequence promotes chromatin loops that straddle the interchromosomal target sequences of this caRNA. These data suggest a feedback loop where the 3D genome modulates the spatial distribution of RNA, which in turn affects the dynamic 3D genome organization.
Open AccessGenome-wide analysis of the interplay between chromatin-associated RNA and 3D genome organization in human cells
The interphase genome is dynamically organized in the nucleus and decorated with chromatin-associated RNA (caRNA). It remains unclear whether the genome architecture modulates the spatial distribution of caRNA and vice versa. Here, we generate a resource of genome-wide RNA-DNA and DNA-DNA contact maps in human cells. These maps reveal the chromosomal domains demarcated by locally transcribed RNA, hereafter termed RNA-defined chromosomal domains. Further, the spreading of caRNA is constrained by the boundaries of topologically associating domains (TADs), demonstrating the role of the 3D genome structure in modulating the spatial distribution of RNA. Conversely, stopping transcription or acute depletion of RNA induces thousands of chromatin loops genome-wide. Activation or suppression of the transcription of specific genes suppresses or creates chromatin loops straddling these genes. Deletion of a specific caRNA-producing genomic sequence promotes chromatin loops that straddle the interchromosomal target sequences of this caRNA. These data suggest a feedback loop where the 3D genome modulates the spatial distribution of RNA, which in turn affects the dynamic 3D genome organization.
- Open Access
- 15 October 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-13
Stress-induced RNA–chromatin interactions promote endothelial dysfunction
Chromatin-associated RNA (caRNA) has been proposed as a type of epigenomic modifier. Here, we test whether environmental stress can induce cellular dysfunction through modulating RNA-chromatin interactions. We induce endothelial cell (EC) dysfunction with high glucose and TNFα (H + T), that mimic the common stress in diabetes mellitus. We characterize the H + T-induced changes in gene expression by single cell (sc)RNA-seq, DNA interactions by Hi-C, and RNA-chromatin interactions by iMARGI. H + T induce inter-chromosomal RNA-chromatin interactions, particularly among the super enhancers. To test the causal relationship between H + T-induced RNA-chromatin interactions and the expression of EC dysfunction-related genes, we suppress the LINC00607 RNA. This suppression attenuates the expression of SERPINE1, a critical pro-inflammatory and pro-fibrotic gene. Furthermore, the changes of the co-expression gene network between diabetic and healthy donor-derived ECs corroborate the H + T-induced RNA-chromatin interactions. Taken together, caRNA-mediated dysregulation of gene expression modulates EC dysfunction, a crucial mechanism underlying numerous diseases.
- 15 October 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-13
Open AccessStress-induced RNA–chromatin interactions promote endothelial dysfunction
Chromatin-associated RNA (caRNA) has been proposed as a type of epigenomic modifier. Here, we test whether environmental stress can induce cellular dysfunction through modulating RNA-chromatin interactions. We induce endothelial cell (EC) dysfunction with high glucose and TNFα (H + T), that mimic the common stress in diabetes mellitus. We characterize the H + T-induced changes in gene expression by single cell (sc)RNA-seq, DNA interactions by Hi-C, and RNA-chromatin interactions by iMARGI. H + T induce inter-chromosomal RNA-chromatin interactions, particularly among the super enhancers. To test the causal relationship between H + T-induced RNA-chromatin interactions and the expression of EC dysfunction-related genes, we suppress the LINC00607 RNA. This suppression attenuates the expression of SERPINE1, a critical pro-inflammatory and pro-fibrotic gene. Furthermore, the changes of the co-expression gene network between diabetic and healthy donor-derived ECs corroborate the H + T-induced RNA-chromatin interactions. Taken together, caRNA-mediated dysregulation of gene expression modulates EC dysfunction, a crucial mechanism underlying numerous diseases.